Study of CX-4945 in Combination With Gemcitabine and Cisplatin for Frontline Treatment of Cholangiocarcinoma
Clinical trial NCT02128282 · COMPLETED
Trial details
- NCT number
- NCT02128282
- Sponsor
- Senhwa Biosciences, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-01
- Primary completion
- 2020-11-06
- Enrollment
- 127
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.